Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Osaka, Japan.
Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Oral Oncol. 2023 Oct;145:106519. doi: 10.1016/j.oraloncology.2023.106519. Epub 2023 Jul 16.
The 8th edition of the International Union Against Cancer Control/American Joint Committee on Cancer Staging System introduced depth of invasion (DOI) and extranodal extension (ENE) into the staging of oral cavity cancer. We evaluated the prognostic ability of this new staging system compared with the 7th edition using clinical DOI (cDOI) and clinical ENE (cENE).
We retrospectively reviewed and restaged 2,118 patients with oral squamous cell carcinoma treated between 2001 and 2018 using cDOI and cENE. Overall and disease-specific survival were used as endpoints to compare the prognostic outcomes of the 7th and 8th editions using Harrell's concordance index (C-index).
In total, 305 (14.4 %) cases were upstaged in the T category, 85 (4.0 %) cases were upstaged in the N category, and 280 (13.2 %) cases were upstaged in the overall TNM stage. The introduction of the cDOI increased the C-index and hazard ratio (HR) for each T category. The introduction of cENE increased the N3b category of 85 cases, bringing the total to 94 cases, thereby widening the differences between each N category. In the 8th edition, the C-index and HR for overall TNM stage increased, and the discrimination between stage groups improved.
The 8th edition of the TNM clinical staging system using cDOI and cENE predominantly identified patients with a high mortality rate, thus improving the ability to discriminate and prognosticate oral cancer.
国际抗癌联盟/美国癌症联合委员会第 8 版分期系统将浸润深度(DOI)和淋巴结外侵犯(ENE)纳入口腔癌分期。我们通过临床 DOI(cDOI)和临床 ENE(cENE)评估了该新分期系统与第 7 版的预后能力。
我们回顾性地审查了 2001 年至 2018 年间治疗的 2118 例口腔鳞状细胞癌患者的临床资料,并重新分期。使用 Harrell 一致性指数(C-index)比较第 7 版和第 8 版的预后结局,以总生存率和疾病特异性生存率作为终点。
在 T 分期中,305 例(14.4%)病例升级,85 例(4.0%)病例在 N 分期中升级,280 例(13.2%)病例在整体 TNM 分期中升级。cDOI 的引入增加了每个 T 分期的 C-index 和风险比(HR)。cENE 的引入增加了 85 例 N3b 病例,总数达到 94 例,从而扩大了每个 N 分期之间的差异。在第 8 版中,整体 TNM 分期的 C-index 和 HR 增加,分期组之间的区分度提高。
使用 cDOI 和 cENE 的第 8 版 TNM 临床分期系统主要识别了死亡率较高的患者,从而提高了对口腔癌的区分和预后能力。